申请人:Yoshitomi Pharmaceutical Industries, Ltd.
公开号:EP0068171A1
公开(公告)日:1983-01-05
A dihydropyridine compound of the formula:
or a pharmaceutically acceptable acid addition salt thereof, wherein Het is 5- or 6-membered aromatic heteroaryl, R' and R2 are each lower alkyl, R3 is lower alkyl, R4 is hydrogen, lower alkyl or aralkyl, R5 is lower alkyl or aralkyl, and n is 1 or 2. Such compounds are useful as therapeutic agents for myocardial and cerebral ischemic syndroms and hypertension.
式中的二氢吡啶化合物:
或其药学上可接受的酸加成盐,其中 Het 为 5 或 6 元芳香杂芳基,R'和 R2 各为低级烷基,R3 为低级烷基,R4 为氢、低级烷基或芳烷基,R5 为低级烷基或芳烷基,n 为 1 或 2。这类化合物可作为心肌和脑缺血综合症及高血压的治疗剂。